Current evidence for transcarotid artery stenting with flow reversal as the preferred carotid artery stenting...

Area of Science:

• Vascular Surgery
• Interventional Cardiology
• Neurology

Background:

• Transfemoral carotid artery stenting (TF-CAS) is a minimally invasive treatment for carotid atherosclerotic disease.
• TF-CAS outcomes in symptomatic or high-risk patients have not matched endarterectomy.
• Embolic risk is a significant concern with the transfemoral approach.

Purpose of the Study:

• To evaluate Transcarotid artery revascularization (TCAR) as an alternative to TF-CAS.
• To highlight the neuroprotection system of TCAR in reducing embolic events.
• To compare the benefits of TCAR versus TF-CAS.

Main Methods:

• TCAR utilizes a flow reversal neuroprotection system.
• This system is designed to mitigate embolic risks inherent in TF-CAS.
• Ongoing research and accumulating evidence support TCAR's efficacy.

Main Results:

• TCAR demonstrates reduced stroke or death benefits compared to the transfemoral approach.
• The flow reversal system in TCAR aims to minimize embolic complications.
• While randomized trials are pending, clinical adoption is growing.

Conclusions:

• TCAR is emerging as a preferred method for carotid artery stenting.
• The procedure offers potential advantages in reducing stroke and death.
• Further randomized trials are needed to confirm TCAR's superiority over TF-CAS.